Table 1B. Detailed histological features of cases grouped by pre- and post-operative histology.
|
Hysterectomy histology report |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
G1 endometrioid |
G2 endometrioid |
|
|||||||||||
| Total | DMI | CxSI | LVSI | LVSI/CxSI no DMI | Total | DMI | CxSI | LVSI | LVSI/CxSI no DMI | G3 | HR | Total | |
|
Biopsy report | |||||||||||||
| G1 endometrioid |
199 (78%) |
44 |
17 |
31 |
15 |
45 (18%) |
19 |
11 |
14 |
6 |
6 (2%) |
5 (2%) |
255 |
| G2 endometrioid |
19 (15%) |
5 |
2 |
2 |
2 |
74 (59%) |
21 |
19 |
23 |
18 |
20 (16%) |
12 (10%) |
125 |
| G3 endometrioid |
1 (1%) |
0 |
0 |
0 |
0 |
6 (7%) |
4 |
1 |
2 |
0 |
57 (68%) |
20 (24%) |
84 |
| HR non-endometrioid | 1 (0.5%) | 0 | 1 | 0 | 1 | 3 (1.6%) | 0 | 0 | 0 | 0 | 9 (5%) | 176 (93%) | 189 |
Abbreviations: CxSI=cervical stromal invasion; DMI=deep myometrial invasion; G1,2,3=grade 1, 2 and 3 endometrioid adenocarcinoma of the endometrium; HR=non endometrioid high risk histologies, including serous endometrial cancer, clear cell adenocarcinoma and carcinosarcoma of the uterus; LVSI=lymphovascular space invasion.